Study found DNA-based screen was more than 90 percent accurate in predicting recurrence
by Mihyun on Wed Mar 28, 2007 12:00 AM
by Oncrx on Wed Mar 28, 2007 12:00 AM
by Njtwinmom on Wed May 02, 2007 12:00 AM
Both are wonderful drugs, and very, very effective. My Mom had problems initially, as well, but these drugs make all the difference. Sometimes your insurance will dictate which one you are "allowed" to have. Neulasta is a one shot deal, and the Neupegen, is given 4 days in a row.
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.